Bradley Rockwell MD (He/Him)

Transplant Hematologist

Summary

Bradley Rockwell, M.D. is a transplant hematologist at the Barbara Ann Karmanos Cancer Institute and Assistant Professor of Oncology at Wayne State University School of Medicine. He specializes in bone marrow transplantation and the treatment of leukemia, lymphoma, multiple myeloma, myelodysplasia, and non-Hodgkin lymphoma. His research focuses on improving outcomes in allogeneic stem cell transplants and developing low-dose treatment approaches to reduce side effects. Board-certified in internal medicine and hematology, Dr. Rockwell is dedicated to advancing innovative therapies while providing compassionate, patient-centered care.

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2022 - 2025
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2018 - 2021
The University of Toledo College of MedicineClass of 2018
University of CincinnatiBS, Exercise Science, 2009 - 2013

PubMed

Treatment of-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclax.
Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, Bradley Rockwell, Yogen Saunthararajah
Haematologica. 2026-04-02
2 citations
Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal Expansion.
Divij Verma, Rachel Zeig-Owens, David G Goldfarb, Leah Kravets, Kith Pradhan
Cancer Discovery. 2025-12-02
Hematopoietic Stem Cell Transplant in Adult Patients with Fanconi Anemia: A Review.
Bradley Rockwell, Prakriti Ramamurthy, Jhannine Alyssa Verceles, Amanda Lombardo, Amit Verma
Diseases. 2025-06-25

Abstracts/Posters

Highly Effective Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Helps Overcome Social Determinants of Health in Medically Underserved Populations
Rockwell B, Dhanaraj N, Forsberg M, Goel S, Levitz D, Gupta R, Shapiro L, Kornblum N, Feldman E., ASH Annual Meetings 2024
Metronomic Low-Dose Regimen of Decitabine and Venetoclax Is Safe and Efficacious for Chronic Myelomonocytic Leukemia
Rockwell B, Mantzaris I, Shastri A, Gritsman K, Sica A, Kornblum N, Shah N, Levitz D, Shapiro L, Gupta R, Munoz A, Dhawan A, Fehn K, Comas M, Verceles J, Cooper D, Kon..., ASH Annual Meetings 2024
G12D Specific Inhibitors Relieve Erythroid Differentiation Block and Modulate Inflammatory Pathways at the Single Cell Level in Myeloid Malignancies.
Kravets L, Saurty-Seerunghen M, Verma D, Fromowitz A, Sahu S, Rockwell B, Sakaguchi O, Narayanagari S, Rivera M, Gordon-Mitchell S, Aluri S, Wang J, LaFave L, Konoplev..., ASH Annual Meetings 2024

Fellow ResearcherDetermining the role of glutaminase inhibition in resistant acute lymphoblastic anemia. Detecting early signs of myeloid malignancies in first responders exposed to the WTC 911 disaster.2023 - Present
Research InternOrganized and coordinated use of cadavers for study of a new objective technique to diagnose ACL tears.2015 - Present
Clinical Research MemberResearch focused on health-related outcomes for patients with acute leukemia. Specifically focusing on the role race and ethnicity play in survival outcomes in this population. Position includes: study design, data collection, interpretation, and manuscript writing.2019 - 2021
Lab Manager/Recruitment Coordinator (Research Lab)2013 - 2014